Method for producing quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease

A technology for bronchitis and chicken infectivity, applied in antiviral agents, pharmaceutical formulas, virus antigen components, etc., can solve the problems of uncontrollable epidemic development, single traditional vaccine, and affecting production performance, so as to reduce the occurrence of epidemic diseases and The effect of spreading, rapid antibody production, and long protection period

Active Publication Date: 2011-05-25
YEBIO BIOENG OF QINGDAO
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] There are many varieties of commercial products on the market at home and abroad, but they are all single traditional vaccines. Multiple use of vaccines, especially inactivated vaccines, not only increases the burden of manpower and material resources on the chicken farm, but also causes th...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for producing quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] (1) Antigen preparation and inspection of semi-finished products:

[0074] 1. Preparation of Chicken Newcastle Disease Virus Liquid

[0075] (1) Inoculation Take the virus seeds for production and make appropriate dilution with sterilized physiological saline (such as 10 -4 or 10 -5 ), inoculate 6528 10-11-day-old susceptible chicken embryos, 0.1ml per embryo, seal the pinhole after inoculation, and continue incubation at 36-37°C without turning the embryos.

[0076] (2) Incubation and observation After chicken embryos were inoculated, the embryos were photographed once a day, and the chicken embryos that died 60 hours ago were discarded. Thereafter, the embryos were photographed once every 4-6 hours, and the dead embryos were taken out at any time until 96 hours, regardless of whether they were dead or not, all were taken out, the air chamber was upward, and they were cooled at 2-8°C for 12-24 hours.

[0077] (3) Harvesting Take out the cooled chicken embryos, and h...

Embodiment 2

[0121] Product testing

[0122] 1. traits

[0123] Appearance Milky white emulsion.

[0124] Dosage form water-in-oil type. Take a clean straw, suck a small amount of vaccine and drop it into cold water, except for the first drop, it should not spread.

[0125] Stability Take 10ml of the vaccine and put it into a centrifuge tube, centrifuge at 3000r / min for 15 minutes, the water precipitated at the bottom of the tube should be ≤0.5ml.

[0126] Viscosity Use a 1ml straw (the inner diameter of the lower mouth is 1.2mm, and the inner diameter of the upper mouth is 2.7mm) to draw 1ml of vaccine at about 25°C, let it flow out vertically and naturally, and record the time required for the outflow of 0.4ml, which should be within 6 seconds.

[0127] 2. Sterility test According to the current "Chinese Veterinary Pharmacopoeia", it should grow aseptically.

[0128] 3. Safety inspection Use 10 SPF chickens aged 7 to 14 days, inject 1ml of vaccine subcutaneously in each muscle or nec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for producing a quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease. In the method, the inactivated vaccine is prepared by adopting a newcastle disease virus La Sota strain, an infectious bronchitis virus M41 strain, an avian influenza virus (H9 subtype) YBF003 strain, and an Escherichia coli genetic engineering bacteria E. coil BL21/pET28a-VP2 strain which expresses an infectious bursal disease virus VP2 protein serving as production bacteria toxic species, a super concentration process and a high-quality adjuvant. After immunizing animals, antibodies are produced rapidly; the potency is high; the protection period is long; and the outbreak and the spreading of epidemic diseases are reduced.

Description

technical field [0001] The invention relates to a method for preparing an oil-emulsion vaccine for preventing Newcastle disease, infectious bronchitis, avian influenza (subtype H9) and infectious bursal disease in chickens, and belongs to the field of veterinary biological products. Background technique [0002] Newcastle disease (ND) has a high morbidity and fatality rate, and it occurs frequently all over the world. Once it breaks out, it will bring a devastating blow to the poultry industry. It is a major infectious disease that endangers the poultry industry. OIE lists it as a Category A disease. (Yin Zhen, Liu Jinghua, 1997. Animal Virology. Beijing. Science Press) [0003] Chicken infectious bronchitis (Infectious Bronchitis, IB) infection can lead to slow growth of chicks and broilers, decreased egg production and decreased egg quality of laying hens. The OIE lists it as a Category B disease. (Yin Zhen, Liu Jinghua, 1997. Animal Virology. Beijing. Science Press) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/295A61P31/14A61P31/16A61K39/12A61K39/145A61K39/17A61K31/215
Inventor 李陆梅宫晓李昌友左青山李晓林孙健
Owner YEBIO BIOENG OF QINGDAO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap